I am not very impressed with the latest update or the company.
After the last update I emailed John Cowan on April 11 and asked: “It’s all very well putting in a statement like ‘maximising the number and quality of target opportunities for achieving revenue in the near future’, but can you please elaborate on what these opportunities might be”.
He replied and said he no longer worked for LCT and I should email the CEO Ken Taylor at [email protected].
I have emailed Ken three times including the last one when I demanded an answer and he still hasn’t got back to me.
Ann: NTCELL and Parkinsons trial update, page-7
-
- There are more pages in this discussion • 289 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $6.268K | 895.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4707556 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1255620 | 12 |
View Market Depth
| Last trade - 15.50pm 12/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |